当前位置: X-MOL 学术J. Hematol. Oncol. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Correction: hUC-EVs-ATO reduce the severity of acute GVHD by resetting inflammatory macrophages toward the M2 phenotype
Journal of Hematology & Oncology ( IF 29.5 ) Pub Date : 2022-07-31 , DOI: 10.1186/s13045-022-01323-2
Yan Su 1, 2, 3, 4 , Xueyan Sun 1, 2, 3, 4 , Xiao Liu 1, 2, 3, 4 , Qingyuan Qu 1, 2, 3, 4 , Liping Yang 1, 2, 3, 4 , Qi Chen 1, 2, 3, 4 , Fengqi Liu 1, 2, 3, 4 , Yueying Li 5, 6 , Qianfei Wang 5, 6 , Bo Huang 7 , Xiao-Hui Zhang 1, 2, 3, 4 , Xiao-Jun Huang 1, 2, 3, 4
Affiliation  


The original article [1] contained errors in the names of co-authors, Xiao-Jun Huang and Xiao-Hui Zhang which have since been corrected.

  1. Su Y, Sun X, Liu X, et al. hUC-EVs-ATO reduce the severity of acute GVHD by resetting inflammatory macrophages toward the M2 phenotype. J Hematol Oncol. 2022;15:99. https://doi.org/10.1186/s13045-022-01315-2.

    Article PubMed PubMed Central Google Scholar

Download references

Author notes
  1. Yan Su and Xueyan Sun have contributed equally to this work

Authors and Affiliations

  1. Peking University People’s Hospital, Peking University Institute of Hematology, No. 11 Xizhimen South Street, Xicheng District, Beijing, China

    Yan Su, Xueyan Sun, Xiao Liu, Qingyuan Qu, Liping Yang, Qi Chen, Fengqi Liu, Xiao-Hui Zhang & Xiao-Jun Huang

  2. Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China

    Yan Su, Xueyan Sun, Xiao Liu, Qingyuan Qu, Liping Yang, Qi Chen, Fengqi Liu, Xiao-Hui Zhang & Xiao-Jun Huang

  3. Collaborative Innovation Center of Hematology, Peking University, Beijing, China

    Yan Su, Xueyan Sun, Xiao Liu, Qingyuan Qu, Liping Yang, Qi Chen, Fengqi Liu, Xiao-Hui Zhang & Xiao-Jun Huang

  4. National Clinical Research Center for Hematologic Disease, Beijing, China

    Yan Su, Xueyan Sun, Xiao Liu, Qingyuan Qu, Liping Yang, Qi Chen, Fengqi Liu, Xiao-Hui Zhang & Xiao-Jun Huang

  5. CAS Key Laboratory of Genomic and Precision Medicine, Collaborative Innovation Center of Genetics and Development, Beijing Institute of Genomics, Chinese Academy of Sciences, Beijing, China

    Yueying Li & Qianfei Wang

  6. Chinese Academy of Sciences, China National Center for Bioinformation, Beijing, China

    Yueying Li & Qianfei Wang

  7. Department of Immunology, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences, Beijing, China

    Bo Huang

Authors
  1. Yan SuView author publications

    You can also search for this author in PubMed Google Scholar

  2. Xueyan SunView author publications

    You can also search for this author in PubMed Google Scholar

  3. Xiao LiuView author publications

    You can also search for this author in PubMed Google Scholar

  4. Qingyuan QuView author publications

    You can also search for this author in PubMed Google Scholar

  5. Liping YangView author publications

    You can also search for this author in PubMed Google Scholar

  6. Qi ChenView author publications

    You can also search for this author in PubMed Google Scholar

  7. Fengqi LiuView author publications

    You can also search for this author in PubMed Google Scholar

  8. Yueying LiView author publications

    You can also search for this author in PubMed Google Scholar

  9. Qianfei WangView author publications

    You can also search for this author in PubMed Google Scholar

  10. Bo HuangView author publications

    You can also search for this author in PubMed Google Scholar

  11. Xiao-Hui ZhangView author publications

    You can also search for this author in PubMed Google Scholar

  12. Xiao-Jun HuangView author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Xiao-Hui Zhang or Xiao-Jun Huang.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

Verify currency and authenticity via CrossMark

Cite this article

Su, Y., Sun, X., Liu, X. et al. Correction: hUC-EVs-ATO reduce the severity of acute GVHD by resetting inflammatory macrophages toward the M2 phenotype. J Hematol Oncol 15, 102 (2022). https://doi.org/10.1186/s13045-022-01323-2

Download citation

  • Published:

  • DOI: https://doi.org/10.1186/s13045-022-01323-2

Share this article

Anyone you share the following link with will be able to read this content:

Sorry, a shareable link is not currently available for this article.

Provided by the Springer Nature SharedIt content-sharing initiative

更新日期:2022-07-31
down
wechat
bug